SCHEMBL1245078

SCHEMBL1245078

CC1=C(O)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3892054 0.97
SCHEMBL3405984 0.97 TSHR (0.30)
SCHEMBL6903042 0.97 TSHR (0.30)
SCHEMBL19151110 0.97 TSHR (0.30)
SCHEMBL6903046 0.97 TSHR (0.30)
SCHEMBL3887653 0.97
SCHEMBL1660770 0.93
SCHEMBL2925219 0.77
SCHEMBL2925224 0.77
SCHEMBL2925223 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361350-B2 Silver nanoparticle ink composition XEROX CORPORATION (US) 2013-01-29 US claimed
US-20100143591-A1 SILVER NANOPARTICLE INK COMPOSITION XEROX CORPORATION (US) 2010-06-10 US claimed
US-20260049067-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl 3 * 6H2O AS CATALYST SALUD & SEMILLAS S L (ES) 2026-02-19 US disclosed
EP-4565573-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST Salud & Semillas, S.L. (ES) 2025-06-11 EP disclosed
WO-2024028516-A1 CANNABINOID SYNTHESIS STARTING OUT FROM OLIVETOL AND TERPENE IN DICHLOROMETHANE WITH FeCl3 * 6H2O AS CATALYST SALUD & SEMILLAS, S.L. (ES) 2024-02-08 WO disclosed
US-11814401-B2 Luminescent material and electroluminescent display device using the same LG DISPLAY CO., LTD (KR) 2023-11-14 US disclosed
EP-3235646-B1 METHOD OF FORMING PIEZO DRIVER ELECTRODES XEROX CORP (US) 2022-03-16 EP disclosed
WO-2020228789-A1 3-ARYLOXYL-3-FIVE-MEMBERED HETEROARYL PROPYLAMINE COMPOUND, AND CRYSTAL FORM AND USE THEREOF 上海璃道医药科技有限公司 2020-11-19 WO disclosed
US-10675842-B2 Transparent electrode and organic electronic device including the same Konica Minolta, Inc. (JP) 2020-06-09 US disclosed
CN-104922128-B Inhibitors of influenza virus replication 沃泰克斯药物股份有限公司 2019-12-20 CN disclosed
CN-110540538-A Inhibitors of influenza virus replication VERTEX PHARMA 2019-12-06 CN disclosed
US-20070197492-A1 Modulation of Pathogenicity QUONOVA, LLC 2007-08-23 US disclosed
US-20070184014-A1 Modulation of Pathogenicity QUONOVA, LLC 2007-08-09 US disclosed
US-20070093534-A1 Modulation of Pathogenicity QUONOVA, LLC 2007-04-26 US disclosed
US-7038069-B2 Process for oxidizing carbon-carbon double bond and process for producing oxidized compounds SHOWA DENKO K.K. (JP) 2006-05-02 US disclosed
EP-1580190-A1 METHOD OF OXIDIZING CARBON-CARBON DOUBLE BOND AND PROCESS FOR PRODUCING OXIDIZED COMPOUND Showa Denko K.K. (JP) 2005-09-28 EP disclosed
US-20040122243-A1 Process for oxidizing carbon-carbon double bond and process for producing oxidized compounds SHOWA DENKO K.K. (JP) 2004-06-24 US disclosed
US-5019628-A Silicone containing acrylic star polymers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-28 US disclosed
US-4154301-A Surfactant oil recovery process usable in a formation having high salinity connate water TEXACO INC. (US) 1979-05-15 US disclosed
US-4104310-A COMPLEXES OF DIALKYL SULFOXIDES AND TRANSITION METAL SALTS SUN VENTURES, INC. (US) 1978-08-01 US disclosed